Abstract 203
Background: Cardiopulmonary bypass (CPB) in children with congenital heart disease is associated with significant morbidity increased in patients with CLS, associated with complement and contact activation.
Subjects, Measurements: Influence of clinical parameters and serological measurements of complement and contact system and C1-Inh concentration and -activation were prospectively evaluated in 37 infants undergoing surgery with CPB to find out what are the main predictors for CLS. In 10 infants 500 IE C1-Inh (Berinert®) was given immediately after surgery. 5 serial blood samples were collected from the begin of surgery up to 48 h later.
Results: All 37 infants showed complement and contact activation, 12 developed postoperative CLS. Levels of C5a, C1q, C3c were elevated in the CLS group. Younger age and longer bypasstime had a strong correlation to CLS. C1-Inh concentration and -activation is lower in the CLS-group (p<.003). In the substitution group we found sign. higher levels of C1-Inh concentration and -activation and a decrease of C1q and C3a (p<.05) 24 h after surgery.
Conclusions: Before CLS shows clinical evidence, we observe a decrease of C1-Inh. Early substitution of C1-Inh is an approach promising reduction of CLS.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stiller, B., Dähnert, I., Sonntag, J. et al. C1-Esterase Inhibitor (C1-Inh) for prevention of capillary leak syndrome (CLS) in infants after cardiac surgery?. Pediatr Res 45, 921 (1999). https://doi.org/10.1203/00006450-199906000-00221
Issue Date:
DOI: https://doi.org/10.1203/00006450-199906000-00221